Loading…

Loading grant details…

Active HORIZON European Commission

Decoding leukemia-immune cell dynamics by organism-wide cellular interaction mapping

€1.5M EUR

Funder European Commission
Recipient Organization Charite - Universitaetsmedizin Berlin
Country Germany
Start Date Feb 01, 2023
End Date Jan 31, 2028
Duration 1,825 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 101078713
Grant Description

Cellular interactions are of fundamental importance in life, orchestrating organismal development, tissue homeostasis and immunity.

In the immune system, cell-cell interactions act as central hubs for information processing and decision making that collectively determine the outcome of complex immune responses.

In leukemias, a cancer originating from immature immune cells, a multilayered network of cellular interactions between immune and leukemic cells underlies effective immune control of the cancer, immune evasion and response to immunotherapies.

However, technical limitations in studying cell-cell interactions restrict our understanding into these highly complex and dynamic processes.

In order to overcome this limitation, I propose to develop a novel interact-omics approach, capable of characterizing millions of cellular interactions across complex organ systems, entire organisms and patient cohorts.

Applying the interact-omics approach to sophisticated leukemia mouse models will enable us to dissect the dynamic cellular interaction networks between antigen-specific T cells, bystander immune cells and leukemic cells that drive anti-leukemia immunity and immune evasion.

In combination with the in vivo perturbation of cellular interactions, this will allow us to systematically decode the cellular logic of how the complex leukemia-immune interplay determines the disease course.

Additionally, by making use of leukemia patient cohorts which are either responsive or non-responsive to immunotherapy treatment, we will unravel previously unknown therapy resistance mechanisms and predict therapy response.

Together, our approach will set the basis for a comprehensive understanding of the leukemia-immune cell crosstalk underlying immune control, immune escape and therapy response, and may serve as a blueprint to fundamentally expand our insights into other biological processes driven by cellular interactions.

All Grantees

Charite - Universitaetsmedizin Berlin

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant